InspireMD GAAP EPS of -$0.17

4 hours ago 1
  • InspireMD press release (NSPR): Q3 GAAP EPS of -$0.17.
  • As of September 30, 2025, cash and cash equivalents and marketable securities were $63.4 million compared to $34.6 million as of December 31, 2024.
  • U.S. revenue for the third quarter was $497,000 and international revenue was $2.0 million. 

Recommended For You

More Trending News

Read Entire Article